Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

31.760
-3.440-9.77%
Volume:10.06M
Turnover:330.37M
Market Cap:7.85B
PE:247.90
High:35.220
Open:35.000
Low:31.200
Close:35.200
52wk High:56.550
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.50
T/O Rate:7.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.128
ROE:-0.02%
ROA:-0.83%
PB:1.37
PE(LYR):247.90
PS:6.01

Loading ...

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

Stock News
·
Aug 28

Movement Alert|CANSINOBIO Falls 5.4% in Regular Trading, Profit-Taking Continues After Multi-Catalyst Rally and H1 Results Release

Market Focus
·
Aug 28

CanSinoBIO Posts 46% Revenue Growth and Near-Break-Even First-Half Result, Boosted by Meningococcal and Pneumococcal Vaccines

Bulletin Express
·
Aug 27

AH Premium Rankings for August 27: A Market Overview

Stock News
·
Aug 27

Movement Alert|CANSINOBIO Declines 5.04% in Regular Trading, Pullback Continues After mRNA Cooperation-Fueled Surge

Market Focus
·
Aug 27

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live
·
Aug 26

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Stock News
·
Aug 26

HK Biotech Shares Surge as CansinoBio Jumps Over 18%

Deep News
·
Aug 26

Movement Alert|CANSINOBIO Rises 14.34% in Regular Trading, Strategic mRNA Tumor Vaccine Partnership with Depushi Bio Announced

Market Focus
·
Aug 26

Movement Alert|CANSINOBIO Rises 6.15% in Regular Trading, Rebounding After Multi-Day Pullback as Broker Flags Severe Undervaluation in mRNA Sector

Market Focus
·
Aug 25

AH Share Premium Rankings: Market Close Update for August 24

Stock News
·
Aug 24

Movement Alert|CANSINOBIO Declines 5.16% in Regular Trading, Profit-Taking Continues After mRNA-Driven Surge

Market Focus
·
Aug 24

AH Share Premium Tracker | August 21 Market Close

Stock News
·
Aug 21

Movement Alert|CANSINOBIO Intraday Decline 7.99%, Pullback Following Previous Sessions Massive mRNA Vaccine-Driven Rally

Market Focus
·
Aug 21

CanSino Biologics' Application for Tetanus Vaccine Approved in China

MT Newswires Live
·
Aug 20

AH Share Premium Ranking Update: August 20 Market Close

Stock News
·
Aug 20

Chinese Vaccine Makers Jump on News of Key Success in Cancer Treatment, CanSino Leads

Reuters
·
Aug 20

CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform

Stock News
·
Aug 20

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Stock News
·
Aug 20

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20